Concentric Capital Strategies’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,828	Closed	-$1.35M	–	309
2024 Q2	$1.35M	Buy	4,828 +3,329	+222%	+$933K	0.07%	208
2024 Q1	$400K	Buy	+1,499	New	+$400K	0.02%	251